Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages.
It has been proposed that mitochondrial dysfunction is involved in the pathogenesis of type 2 diabetes (T2D). To dissect the underlying mechanisms, we performed a multiplexed proteomics study on liver mitochondria isolated from a spontaneous diabetic rat model before/after they were rendered diabetic. Altogether, we identified 1091 mitochondrial proteins, 228 phosphoproteins, and 355 hydroxyproteins. Mitochondrial proteins were found to undergo expression changes in a highly correlated fashion during T2D development. For example, proteins involved in beta-oxidation, the tricarboxylic acid cycle, oxidative phosphorylation, and other bioenergetic processes were coordinately up-regulated, indicating that liver cells confronted T2D by increasing energy expenditure and activating pathways that rid themselves of the constitutively increased flux of glucose and lipid. Notably, activation of oxidative phosphorylation was immediately related to the overproduction of reactive oxygen species, which caused oxidative stress within the cells. Increased oxidative stress was also evidenced by our post-translational modification profiles such that mitochondrial proteins were more heavily hydroxylated during T2D development. Moreover, we observed a distinct depression of antiapoptosis and antioxidative stress proteins that might reflect a higher apoptotic index under the diabetic stage. We suggest that such changes in systematic metabolism were causally linked to the development of T2D. Comparing proteomics data against microarray data, we demonstrated that many T2D-related alterations were unidentifiable by either proteomics or genomics approaches alone, underscoring the importance of integrating different approaches. Our compendium could help to unveil pathogenic events in mitochondria leading to T2D and be useful for the discovery of diagnosis biomarker and therapeutic targets of T2D.
Deng
Wen-Jun
WJ
Key Laboratory of Systems Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Nie
Song
S
Dai
Jie
J
Wu
Jia-Rui
JR
Zeng
Rong
R
D000818:Animals; D015153:Blotting, Western; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D020869:Gene Expression Profiling; D006900:Hydroxylation; D013058:Mass Spectrometry; D055432:Metabolomics / Q000379:methods; D008930:Mitochondria, Liver / Q000378:metabolism*; D024101:Mitochondrial Proteins / Q000235:genetics / Q000378:metabolism; D008954:Models, Biological; D010750:Phosphoproteins / Q000032:analysis* / Q000235:genetics; D011499:Protein Processing, Post-Translational; D011506:Proteins / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D020543:Proteome / Q000032:analysis* / Q000235:genetics; D040901:Proteomics / Q000379:methods; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D024101:Mitochondrial Proteins; D010750:Phosphoproteins; D011506:Proteins; D020543:Proteome; D012333:RNA, Messenger
Arch Med Res. 2005 May-Jun;36(3):197-209
15925010
Electrophoresis. 2007 Dec;28(23):4311-9
17987634
Exp Clin Endocrinol Diabetes. 2002 Sep;110(6):291-7
12373633
Diabetes. 1996 Feb;45(2):113-26
8549853
Proteomics. 2008 Apr;8(8):1564-75
18348319
Obes Res. 2005 Apr;13(4):678-86
15897476
Biochimie. 1998 Oct;80(10):803-6
9893938
J Endocrinol. 2009 Feb;200(2):151-7
18948349
Diabetologia. 2007 Feb;50(2):268-77
17187250
Nat Methods. 2007 Mar;4(3):207-14
17327847
Cell. 2008 Jul 11;134(1):112-23
18614015
Mol Cell Biochem. 2003 Apr;246(1-2):163-70
12841358
Rinsho Byori. 1993 Jun;41(6):673-8
8361034
Mol Cell Proteomics. 2006 Apr;5(4):608-19
16415296
Diabetes. 2002 Oct;51(10):2944-50
12351431
Tidsskr Nor Laegeforen. 2006 Mar 9;126(6):756-9
16541168
Nature. 2001 Dec 13;414(6865):782-7
11742409
Anal Chem. 1995 Apr 15;67(8):1426-36
7741214
Obesity (Silver Spring). 2008 May;16(5):958-64
18277391
Diabetologia. 2000 Mar;43(3):265-77
10768087
Essays Biochem. 1994;28:13-25
7925316
Mol Cell Proteomics. 2008 Aug;7(8):1434-51
18448419
Biochem J. 1998 Aug 1;333 ( Pt 3):519-25
9677308
Proteomics. 2007 Apr;7(7):1150-63
17390297
Obesity (Silver Spring). 2008 Dec;16(12):2601-9
18846047
Am J Physiol. 1996 Oct;271(4 Pt 1):E755-62
8897865
J Biol Chem. 1998 Oct 30;273(44):28603-9
9786852
Mol Cell Proteomics. 2004 May;3(5):441-55
14739257
Free Radic Biol Med. 1999 Dec;27(11-12):1151-63
10641706
Nat Genet. 2006 May;38(5):576-82
16582907
Physiol Genomics. 2006 Aug 16;26(3):192-201
16684804
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13207-12
14576278
Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):495-504
15926190
Tohoku J Exp Med. 1976 May;119(1):85-90
951706
Biochem J. 1980 Jun 15;188(3):601-8
7470023
Proteome Sci. 2009 Apr 17;7:17
19374746
Mol Cell Proteomics. 2007 Apr;6(4):669-76
17208939
Diabetes. 1999 Aug;48(8):1593-9
10426378
Endocr Rev. 2008 Oct;29(6):647-76
18606873
Nat Methods. 2008 Apr;5(4):319-22
18345006
Cell. 2003 Nov 26;115(5):629-40
14651853
Novartis Found Symp. 2001;235:247-63; discussion 263-6
11280029
PLoS One. 2008 Sep 16;3(9):e3224
18795103
Acta Diabetol. 2008 Jun;45(2):75-81
18292963
Biochem J. 1999 Mar 15;338 ( Pt 3):569-82
10051425
Science. 2005 Jan 21;307(5708):384-7
15662004
J Proteome Res. 2005 Nov-Dec;4(6):1931-41
16335937
J Intern Med. 2001 May;249(5):451-9
11350569
J Mol Endocrinol. 2005 Apr;34(2):299-315
15821098
Mol Cell Proteomics. 2006 Dec;5(12):2392-411
17000643
Diabetes. 2008 Jun;57(6):1446-54
18511445
J Proteome Res. 2004 May-Jun;3(3):495-505
15253431
Nihon Rinsho. 1997 Oct;55 Suppl:603-8
9392169
Methods Cell Biol. 2007;80:179-97
17445695
Curr Diab Rep. 2008 Jun;8(3):173-8
18625112
Diabetes. 2007 Jul;56(7):1751-60
17456854
J Med Chem. 2004 Aug 12;47(17):4113-7
15293979
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11040-4
7972005
Diabetes. 2003 Jan;52(1):102-10
12502499
J Biol Chem. 2004 Feb 20;279(8):6261-70
14638678